Kenvue Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

49177J102
SEDOL

BQ84ZQ6
CIK

0001944048

www.kenvue.com
LEI:
New: Infographics X-Lab
FIGI: BBG01C79X561
KVUE

Kenvue Inc.
GICS: - · Sector: Consumer Defensive · Sub-Sector: Household & Personal Products
AI
PROFILER
NAME
Kenvue Inc.
ISIN
US49177J1025
TICKER
KVUE
MIC
XNYS
REUTERS
KVUE.N
BLOOMBERG
KVUE US
F&G: 58
5.608,62 S&P · 23,60 Vola-Index · 94.243,91 BTC · 1,13506 EURUSD
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 24.04.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) will announce its first quarter 2025 financial results before market open on May 8, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations...
Wed, 16.04.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors has declared a quarterly dividend of $0.205 per share on its common stock. This quarterly dividend is payable on May 28, 2025, to shareholders of record as of the close of business on May 14, 2025. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company...
Wed, 16.04.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundation for transforming digital operations through advanced Artificial Intelligence (AI) technologies. These technologies include machine-enabled collab...
Wed, 19.03.2025       Kenvue
US49177J1025

Today, Kenvue Inc. (NYSE: KVUE) held a ribbon-cutting ceremony for its new 290,000 sq. ft. global headquarters in Summit, New Jersey. The Company – which marked the start of construction of its 100,000 sq. ft. state-of-the-art Science and Innovation Lab at a ceremony last year – has officially moved its headquarters from Skillman to Summit, New Je...
Fri, 07.03.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) will share new clinical data demonstrating how its iconic brands are leveraging the latest science to shape the future of the Skin Health & Beauty category at the 2025 American Academy of Dermatology (AAD) Annual Meeting, set for March 7-11, 2025 at the Orlando Convention Center in Orlando, Florida. In findings from t...
Wed, 05.03.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero, Ltd., and Erica Mann, former President and Head of Bayer’s Consumer Health Division, to the Company’s Board of Directors (the “Board”). Additionally,...
Thu, 13.02.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available ...
Thu, 06.02.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE), today announced financial results for the full year and fiscal fourth quarter ended December 29, 2024. “We delivered on our 2024 profit commitments despite headwinds that resulted in softer than expected sales growth and we enter 2025 as a more competitive company with stronger foundations,” said Thibaut Mongon, Chief E...
Wed, 05.02.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to Starboard Value’s (“Starboard”) submission of four nominees to stand for election to the Kenvue Board of Directors at Kenvue’s 2025 Annual Meeting of Shareholders: The Kenvue Board and managem...
Thu, 23.01.2025       Kenvue
US49177J1025

Kenvue Inc. (NYSE: KVUE) will announce its fourth quarter and full year 2024 financial results before market open on February 6, 2025. The company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss its financial results. The conference call can be accessed by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from in...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S